{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Ftheidi.simplecast.com%2Fepisodes%2Fthe-state-of-market-access-dpkE1Ky2","width":444,"version":"1.0","type":"rich","title":"The State of Market Access","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9660dd78-6154-402f-87c9-4f85da5cd51a/0d2a0f98-2268-4f07-93dc-0f411170596e/masthead-square-the-idi.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/0a262cbe-0b06-46bb-92ee-7b0d328e0389\" height=\"200\" width=\"100%\" title=\"The State of Market Access\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In today's episode, we discuss the state of market access. How did pharma navigate an uncertain environment in 2022, and what lies ahead in 2023? Susan Weber, a Principal with Valuate, joins The IDI as our guest -- and she has the results of a new survey of payer executives that will help answer these questions. "}